Imagin Medical Posts New Presentation on its Website
(firmenpresse) - Imagin Medical Posts New Presentation on its Website
Vancouver, B.C. and Boston, MA, January 9, 2018 - Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (Imagin or the Company) today announced that, ahead of its planned meetings with members of the investment community over the coming weeks, it has made its updated corporate presentation available on the Companys website. The presentation can be accessed by visiting the Investors section of www.imaginmedical.com.
About Imagin Medical
Imagin is developing powerful new imaging solutions for the detection and visualization of cancer. The Company believes its technology will radically improve physicians ability to detect cancer with minimally invasive endoscopes, improving their ability to visualize, identify and remove cancerous cells. Imagins initial target market is bladder cancer, the sixth most common cancer in the U.S., and the costliest cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, Imagins advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors. Learn more at www.imaginmedical.com.
Forward-Looking Statements
Information set forth in the corporate presentation referenced in this press release contains forward-looking statements. These statements reflect managements current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Companys control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Specifically, there is no assurance the Companys imaging system will work in the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
Contacts:
Stephen Kilmer, Investor Relations
Telephone: 647-872-4849
Email: stephen(at)kilmerlucas.com
Jim Hutchens, President & CEO
Telephone: 833-246-2446
Email: jhutchens(at)imaginmedical.com
Leseranfragen:
" alt="Copper Mountain Mining Achieves 2018 Production Guidance and Announces Three-Year Guidance
Datum: 09.01.2019 - 22:33 Uhr
Sprache: Deutsch
News-ID 586097
Anzahl Zeichen: 2679
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 253 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Imagin Medical Posts New Presentation on its Website
"
steht unter der journalistisch-redaktionellen Verantwortung von
Imagin Medical (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
